UniProt ID | CHMP5_HUMAN | |
---|---|---|
UniProt AC | Q9NZZ3 | |
Protein Name | Charged multivesicular body protein 5 | |
Gene Name | CHMP5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 219 | |
Subcellular Localization |
Cytoplasm, cytosol. Endosome membrane Peripheral membrane protein . Localizes to the midbody of dividing cells. Localized in two distinct rings on either side of the Fleming body. |
|
Protein Description | Probable peripherally associated component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Involved in HIV-1 p6- and p9-dependent virus release.. | |
Protein Sequence | MNRLFGKAKPKAPPPSLTDCIGTVDSRAESIDKKISRLDAELVKYKDQIKKMREGPAKNMVKQKALRVLKQKRMYEQQRDNLAQQSFNMEQANYTIQSLKDTKTTVDAMKLGVKEMKKAYKQVKIDQIEDLQDQLEDMMEDANEIQEALSRSYGTPELDEDDLEAELDALGDELLADEDSSYLDEAASAPAIPEGVPTDTKNKDGVLVDEFGLPQIPAS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Methylation | -----MNRLFGKAKP -----CCCCCCCCCC | 30.05 | - | |
7 | Ubiquitination | -MNRLFGKAKPKAPP -CCCCCCCCCCCCCC | 46.00 | - | |
7 | Acetylation | -MNRLFGKAKPKAPP -CCCCCCCCCCCCCC | 46.00 | 25953088 | |
9 | Malonylation | NRLFGKAKPKAPPPS CCCCCCCCCCCCCCC | 51.00 | 26320211 | |
16 | Phosphorylation | KPKAPPPSLTDCIGT CCCCCCCCHHHHCCC | 50.07 | 28985074 | |
18 | Phosphorylation | KAPPPSLTDCIGTVD CCCCCCHHHHCCCCH | 32.91 | 23090842 | |
23 | Phosphorylation | SLTDCIGTVDSRAES CHHHHCCCCHHHHHH | 10.96 | 23090842 | |
23 | O-linked_Glycosylation | SLTDCIGTVDSRAES CHHHHCCCCHHHHHH | 10.96 | 23301498 | |
26 | Phosphorylation | DCIGTVDSRAESIDK HHCCCCHHHHHHHHH | 29.11 | 25849741 | |
30 | Phosphorylation | TVDSRAESIDKKISR CCHHHHHHHHHHHHH | 34.79 | 26657352 | |
34 | Ubiquitination | RAESIDKKISRLDAE HHHHHHHHHHHHHHH | 42.01 | 24816145 | |
44 | Acetylation | RLDAELVKYKDQIKK HHHHHHHHHHHHHHH | 60.24 | 23236377 | |
44 | Ubiquitination | RLDAELVKYKDQIKK HHHHHHHHHHHHHHH | 60.24 | 21890473 | |
44 | Ubiquitination | RLDAELVKYKDQIKK HHHHHHHHHHHHHHH | 60.24 | 23000965 | |
46 | Ubiquitination | DAELVKYKDQIKKMR HHHHHHHHHHHHHHH | 37.12 | 23000965 | |
50 | Ubiquitination | VKYKDQIKKMREGPA HHHHHHHHHHHCCCH | 34.58 | 23000965 | |
58 | Ubiquitination | KMREGPAKNMVKQKA HHHCCCHHHHHHHHH | 49.02 | 24816145 | |
86 | Phosphorylation | RDNLAQQSFNMEQAN HHHHHHHHHCHHHHC | 13.40 | 21945579 | |
94 | Phosphorylation | FNMEQANYTIQSLKD HCHHHHCHHHHHHHC | 14.29 | 21945579 | |
95 | Phosphorylation | NMEQANYTIQSLKDT CHHHHCHHHHHHHCC | 16.61 | 21945579 | |
98 | Phosphorylation | QANYTIQSLKDTKTT HHCHHHHHHHCCCHH | 33.27 | 21945579 | |
100 | Ubiquitination | NYTIQSLKDTKTTVD CHHHHHHHCCCHHHH | 69.47 | 21890473 | |
100 | Ubiquitination | NYTIQSLKDTKTTVD CHHHHHHHCCCHHHH | 69.47 | 21906983 | |
102 | Phosphorylation | TIQSLKDTKTTVDAM HHHHHHCCCHHHHHH | 28.80 | 23532336 | |
103 | Ubiquitination | IQSLKDTKTTVDAMK HHHHHCCCHHHHHHH | 52.94 | 22817900 | |
110 | Ubiquitination | KTTVDAMKLGVKEMK CHHHHHHHHCHHHHH | 43.75 | 33845483 | |
114 | Acetylation | DAMKLGVKEMKKAYK HHHHHCHHHHHHHHH | 50.74 | 25953088 | |
138 | Sulfoxidation | LQDQLEDMMEDANEI HHHHHHHHHHHHHHH | 2.01 | 30846556 | |
139 | Sulfoxidation | QDQLEDMMEDANEIQ HHHHHHHHHHHHHHH | 6.97 | 30846556 | |
150 | Phosphorylation | NEIQEALSRSYGTPE HHHHHHHHHHHCCCC | 26.65 | 26074081 | |
152 | Phosphorylation | IQEALSRSYGTPELD HHHHHHHHHCCCCCC | 25.25 | 26074081 | |
153 | Phosphorylation | QEALSRSYGTPELDE HHHHHHHHCCCCCCH | 24.73 | 26074081 | |
180 | Phosphorylation | ELLADEDSSYLDEAA HHHCCCCCCHHHHHH | 20.87 | 29759185 | |
219 | Phosphorylation | GLPQIPAS------- CCCCCCCC------- | 35.09 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CHMP5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CHMP5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHMP5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219, AND MASSSPECTROMETRY. |